Alercell Unveils Lena S1® Methylated Genes Diagnostic Test

AI to Revolutionize Oncology Testing on Cancer Day 2024

ALERCELL ANNOUNCES THE LAUNCH OF LENA PAN-MPN qPCR PANEL.

Alercell's Latest Intellectual Property In-License

Alercell receives the Global Excellence Award

Growth Opportunities in Global Precision Health

ALERCELL CELEBRATES NATIONAL CANCER SURVIVORS’ DAY® 2023

ALERCELL LAUNCHES “LENA MOLECULAR DIAGNOSTIC LEUKEMIA PLATFORM”

ALERCELL ANNOUNCES EUROPEAN EXPANSION - OPENING OF ALERCEL UK Ltd

ALERCELL CELEBRATES WORLD CANCER DAY 2023

ALERCELL ANNOUNCES THE LAUNCH OF A NEW WEBSITE